-- Mary Elizabeth Dallas
WEDNESDAY, Jan. 18 (HealthDay News) -- A new vaccine to protect
against meningococcus B, a common cause of bacterial meningitis,
shows promise in clinical trials, researchers in Chile report.
Vaccines that protect from four other strains of
Neisseria meningitides, a bacteria that causes meningococcal disease, are already in use or in the last stages of development, according to a news release from The Lancet. The other strains include A, C, W135 and Y.
The new research examined the effectiveness of the vaccine for
strain B, which remains a significant source of meningococcal
disease in North America, South America and Europe.
Researchers tested the vaccine called 4CMenB at 12 sites in
Chile. More than 1,600 teens aged 11 to 17 were given either one,
two or three doses of the vaccine at one-, two- and three-month
intervals, or a placebo.
After two or three doses, nearly all of the teens had blood test
results that indicated they were protected from meningococcus B,
compared to 92 to 97 percent of teens who got one dose of the
vaccine and 29 to 50 percent who received a placebo.
"This pivotal study shows that two doses of the novel 4CMenB vaccine separated by 1, 2, or 6 months provide a potentially protective immune response in almost 100 percent of adolescents irrespective of previous antibody status," the study authors wrote.
The study is published online Jan. 17 in
The study authors pointed out the vaccine had no harmful effects
on the teens involved in the trial. They added the amount of
protection the vaccine provides will depend on where people live
since strains of the bacteria vary, and more research is needed to
determine how this vaccine will affect other age groups.
"Further study is needed to provide information about the immunogenicity and tolerability of 4CMenB in various age groups, including infants, who bear the largest disease burden worldwide," they wrote.
Meningitis is an inflammation of the membranes covering the
spinal cord and the brain. According to the U.S. Centers for
Disease Control and Prevention, meningitis can be caused by a virus
or a bacteria. The bacterial form is often more severe and can
result in brain damage, hearing loss and death.
Before the 1990s,
Haemophilus influenzae type b (Hib) was the leading cause of
bacterial meningitis. Today, the Hib vaccine is part of routine
The U.S. Centers for Disease Control and Prevention provides
more information on the
prevention and control of meningococcal
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.